GALT - Galectin Therapeutics Stock Trading

Galectin Therapeutics Inc.(NASDAQ: GALT) stock trading, description, contact, officers and directors.

About Galectin Therapeutics Inc.

Galectin is a clinical development stage biopharmaceutical company based in Norcross, Georgia, that is targeting fibrotic diseases and cancer with novel galectin inhibitor compounds. Galectins are a class of proteins made by many cells in the body and are important therapeutic targets because they are the mediators of fundamental biologic mechanisms in pathological processes. Galectin Therapeutics leverages its extensive scientific knowledge of galectins to advance their discovery program including research and discovery of new compounds. Through a relationship with a world class research program at the University of Georgia, the Company focuses on the discovery of new carbohydrate molecules that can be used in the therapy of diseases where galectin proteins play a major role including cancer and inflammatory and fibrotic disorders.

Stock Information

Galectin Therapeutics Inc. Company Name:

GALT Stock Symbol:

NASDAQ Market:

Galectin Therapeutics Inc. Website:

GALT - Galectin Therapeutics Stock Trading

GALT GALT Quote GALT Short GALT News GALT Articles GALT Message Board

Get GALT Alerts

News, Short Squeeze, Breakout and More Instantly...

GALT - Galectin Therapeutics Investor Conference Call and Webinar Taking Place Today

NORCROSS, Ga., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, announced that the Company will host an investor conference call and webinar to discuss the Company’s NASH-RX clini...
GALT - Top Penny Stocks To Watch Before October 2020; 2 Up 88% In Q3

3 Penny Stocks To Watch Today Making New Highs Before Q4 It’s already been a crazy week for penny stocks and we’re only 1 day in. Just like last week, this week kicked off with a volatile penny stock breakout that sparked further momentum for small-caps. Initially, wha...
GALT - Galectin Therapeutics Announces Investor Conference Call and Webinar on September 29, 2020

NORCROSS, Ga., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, announced today that the Company will host an investor conference call and webinar to discuss the Company’s NAS...